Sphera Funds Management Ltd. 13F holdings, Q1 2025
Holdings as of March 31, 2025 · filings on SEC EDGAR · latest filing →
Sphera Funds Management Ltd. disclosed 112 US equity positions worth $405.5m in its Q1 2025 13F filing. The largest position was TEVA at 6.0% of the reported book, followed by SNDX and SNY. Against the Q4 2024 filing, it opened 6 new positions, added to 16 and reduced 20 among the top 50 holdings.
What did Sphera Funds Management Ltd. own in Q1 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2024 |
|---|---|---|---|---|---|---|---|
| 1 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 6.0% | $24.2m | 1,572,181 | 0% | held |
| 2 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 5.0% | $20.4m | 1,663,974 | 20% | added |
| 3 | SNY SANOFI | 4.2% | $16.9m | 304,515 | -21% | reduced | |
| 4 | NVMI NOVA LTD | Technology | 4.1% | $16.7m | 90,697 | 33% | added |
| 5 | AZN ASTRAZENECA PLC | Healthcare | 3.2% | $12.9m | 175,060 | -22% | reduced |
| 6 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 3.1% | $12.7m | 366,608 | -60% | reduced |
| 7 | SRPT SAREPTA THERAPEUTICS INC | Healthcare | 2.5% | $10.1m | 157,931 | 60% | added |
| 8 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 2.4% | $9.7m | 267,385 | 17% | added |
| 9 | LLY ELI LILLY & CO | Healthcare | 2.4% | $9.7m | 11,690 | -11% | reduced |
| 10 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 2.3% | $9.2m | 507,829 | 7% | added |
| 11 | JNJ JOHNSON & JOHNSON | Healthcare | 2.2% | $8.8m | 52,831 | -24% | reduced |
| 12 | NVO NOVO-NORDISK A S | Healthcare | 2.0% | $8.2m | 118,080 | 20% | added |
| 13 | ELDN ELEDON PHARMACEUTICALS INC | 1.9% | $7.8m | 2,307,119 | -10% | reduced | |
| 14 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 1.8% | $7.4m | 465,526 | 144% | added |
| 15 | AMZN AMAZON COM INC | Consumer Cyclical | 1.7% | $7.0m | 36,607 | -42% | reduced |
| 16 | ABBV ABBVIE INC | Healthcare | 1.6% | $6.3m | 30,256 | -12% | reduced |
| 17 | PHVS PHARVARIS N V | 1.5% | $6.0m | 383,856 | -1% | reduced | |
| 18 | ORA ORMAT TECHNOLOGIES INC | Utilities | 1.5% | $5.9m | 84,000 | 6% | added |
| 19 | CYTK CYTOKINETICS INC | Healthcare | 1.4% | $5.8m | 144,961 | -5% | reduced |
| 20 | META META PLATFORMS INC | Communication Services | 1.4% | $5.7m | 9,962 | -53% | reduced |
| 21 | NVS NOVARTIS AG | Healthcare | 1.4% | $5.6m | 50,000 | 0% | held |
| 22 | MRK MERCK & CO INC | Healthcare | 1.3% | $5.3m | 59,600 | 0% | held |
| 23 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 1.3% | $5.3m | 140,660 | 54% | added |
| 24 | ORMAT TECHNOLOGIES INC | 1.3% | $5.2m | 5,037,000 | 0% | held | |
| 25 | NICE NICE LTD | Technology | 1.3% | $5.1m | 33,303 | -22% | reduced |
| 26 | GSK GSK PLC | Healthcare | 1.2% | $5.0m | 130,000 | 0% | held |
| 27 | SEDG SOLAREDGE TECHNOLOGIES INC | Technology | 1.2% | $5.0m | 309,216 | -18% | reduced |
| 28 | ETNBGBP 89BIO INC | 1.1% | $4.5m | 618,343 | 11% | added | |
| 29 | MERUS N V | 1.1% | $4.5m | 106,532 | -18% | reduced | |
| 30 | IMTX IMMATICS N.V | Healthcare | 1.0% | $4.2m | 921,111 | 0% | held |
| 31 | APLSUSD APELLIS PHARMACEUTICALS INC | 1.0% | $4.0m | 181,346 | -12% | reduced | |
| 32 | MAZE MAZE THERAPEUTICS INC | 1.0% | $3.9m | 355,554 | – | new | |
| 33 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 0.9% | $3.6m | 200,000 | -9% | reduced |
| 34 | SVRA SAVARA INC | Healthcare | 0.9% | $3.6m | 1,284,151 | 6% | added |
| 35 | ARWR ARROWHEAD PHARMACEUTICALS IN | Healthcare | 0.9% | $3.5m | 277,550 | 40% | added |
| 36 | DYN DYNE THERAPEUTICS INC | Healthcare | 0.8% | $3.4m | 329,262 | 39% | added |
| 37 | ANNX ANNEXON INC | Healthcare | 0.8% | $3.4m | 1,764,387 | 42% | added |
| 38 | JANX JANUX THERAPEUTICS INC | Healthcare | 0.8% | $3.4m | 125,840 | 84% | added |
| 39 | HELP CYBIN INC | 0.8% | $3.3m | 527,222 | -2% | reduced | |
| 40 | IMVT IMMUNOVANT INC | Healthcare | 0.8% | $3.3m | 194,638 | – | new |
| 41 | NVDA NVIDIA CORPORATION | Technology | 0.8% | $3.2m | 29,605 | – | new |
| 42 | RZLT REZOLUTE INC | 0.8% | $3.1m | 1,081,447 | -7% | reduced | |
| 43 | RNAGBP AVIDITY BIOSCIENCES INC | 0.8% | $3.1m | 106,000 | – | new | |
| 44 | AMGN AMGEN INC | Healthcare | 0.8% | $3.1m | 10,000 | – | new |
| 45 | BIIB BIOGEN INC | Healthcare | 0.8% | $3.1m | 22,738 | 0% | held |
| 46 | ALPHA COGNITION INC | 0.7% | $3.0m | 596,992 | -4% | reduced | |
| 47 | VIGL VIGIL NEUROSCIENCE INC | 0.7% | $2.9m | 1,604,429 | 7% | added | |
| 48 | NTLA INTELLIA THERAPEUTICS INC | Healthcare | 0.7% | $2.7m | 381,080 | -18% | reduced |
| 49 | DAWNGBX DAY ONE BIOPHARMACEUTICALS I | 0.7% | $2.7m | 334,987 | 0% | held | |
| 50 | AMAT APPLIED MATLS INC | Technology | 0.6% | $2.6m | 18,000 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.